C o v Patents’ since 2002

Check on these patents that can be found in the official site of the American Patent Office. https://www.uspto.gov/

Go to this section of their website and key in the following patent numbers: https://patft.uspto.gov/netahtml/PTO/srchnum.htm

Patent Number: 7279327
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=7279327.PN.&OS=PN/7279327&RS=PN/7279327

This is a SARS-Cov-2 patent filed in April 2002 by researchers from University of North Carolina at Chapel Hill and also Ralph Baric for a “an infectious, replication defective, coronavirus particle, that specifically targets lung epithelial cells wherein said cell is a coronavirus permissive cell…..” This virus was genetically modified to infect humans more effectively! The research and development of this research was funded by Dr. Anthony Fauci from the NIH! There were claims that this research was initiated to develop HIV vaccines using coronaviruses as vectors. However, the research deployed genetically modifying platforms to enhance the coronavirus to infect human cells using the ACE2 receptors.

Patent Number: 7220852
;p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=7220852.PN.&OS=PN/7220852&RS=PN/7220852″>https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=7220852.PN.&OS=PN/7220852&RS=PN/7220852

Patent filed in April 2003 by US CDC for the SARS-CoV and SARS-CoV-2 genome. (Note that US laws do not allow a naturally occurring virus to be patented.)

Patent Number: 46592703P and 776521 concerning the SARS-CoV-2 were classified by the CIA and masked in the last 24 hours! (These patents cover PC RCT testing platforms for SARS-CoV-2.)

Patent Number: 7151163
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=7151163.PN.&OS=PN/7151163&RS=PN/7151163

This patent was filed by Sequoia Pharmaceuticals, Inc. on 28th April 2003 for the antivirals to treat SARS-CoV and SARS-CoV-2. The company was later absorbed by Pfizer and Johnson + Johnson.

Patent Number: 9193780
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9193780.PN.&OS=PN/9193780&RS=PN/9193780

Patent filed on 5th June 2008, but approved in 2015, by Ablynx Pharma (former Sequoia Pharmaceuticals) for the polybasic cleavage found on the SARS-CoV-2 genome that allows access to human cells via ACE2 receptors!

Another more than 73 patents were filed between 2003 to 2018 regarding various aspects of the SARS-CoV-2.